Collegium Pharmaceutical Current Ratio 2014-2019 | COLL

Collegium Pharmaceutical current ratio from 2014 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Collegium Pharmaceutical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.25B $0.20B 1.25
2019-03-31 $0.23B $0.19B 1.24
2018-12-31 $0.24B $0.19B 1.26
2018-09-30 $0.22B $0.28B 0.78
2018-06-30 $0.22B $0.27B 0.82
2018-03-31 $0.21B $0.25B 0.83
2017-12-31 $0.13B $0.03B 4.24
2017-09-30 $0.12B $0.03B 4.50
2017-06-30 $0.12B $0.03B 4.22
2017-03-31 $0.14B $0.03B 5.56
2016-12-31 $0.16B $0.03B 6.20
2016-09-30 $0.10B $0.02B 4.29
2016-06-30 $0.12B $0.02B 6.40
2016-03-31 $0.14B $0.01B 12.25
2015-12-31 $0.10B $0.01B 11.49
2015-09-30 $0.11B $0.01B 12.36
2015-06-30 $0.11B $0.01B 18.36
2015-03-31 $0.05B $0.01B 6.98
2014-12-31 $0.00B $0.01B 0.43
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.01B $0.00B 3.17
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.366B $0.280B
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.064B 36.38
Takeda Pharmaceutical (TAK) Japan $26.341B 8.22
Astellas Pharma (ALPMY) Japan $26.215B 12.85
UCB SA (UCBJF) Belgium $15.008B 0.00
Grifols, S.A (GRFS) Spain $15.002B 19.14
Eisai (ESALY) Japan $14.332B 24.64
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.481B 20.45
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.689B 0.00
IPSEN SA ADR (IPSEY) France $8.520B 0.00
Sage Therapeutics (SAGE) United States $8.318B 0.00
Catalent (CTLT) United States $8.054B 32.32
Jazz Pharmaceuticals (JAZZ) Ireland $7.439B 9.79
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.735B 17.02
FibroGen (FGEN) United States $3.750B 93.78
United Therapeutics (UTHR) United States $3.487B 0.00
Tilray (TLRY) Canada $3.415B 0.00
Nektar Therapeutics (NKTR) United States $3.188B 0.00
Evotec AG (EVTCY) Germany $3.120B 42.71
Taro Pharmaceutical Industries (TARO) Israel $3.103B 11.12
Arrowhead Pharmaceuticals (ARWR) United States $2.767B 63.44
PTC Therapeutics (PTCT) United States $2.614B 0.00
Xencor (XNCR) United States $2.284B 49.79
Portola Pharmaceuticals (PTLA) United States $2.085B 0.00
Zogenix (ZGNX) United States $2.057B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.621B 59.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.452B 14.56
Corcept Therapeutics (CORT) United States $1.439B 19.78
Ironwood Pharmaceuticals (IRWD) United States $1.404B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.384B 22.84
Heron Therapeutics (HRTX) United States $1.349B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.205B 0.00
Aerie Pharmaceuticals (AERI) United States $1.129B 0.00
Radius Health (RDUS) United States $1.040B 0.00
ArQule (ARQL) United States $1.039B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.837B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.718B 3.20
TherapeuticsMD (TXMD) United States $0.716B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.552B 0.00
Karyopharm Therapeutics (KPTI) United States $0.545B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.518B 0.00
Akebia Therapeutics (AKBA) United States $0.511B 0.00
Endo (ENDP) Ireland $0.505B 0.89
Aptorum Group (APM) China $0.477B 0.00
Indivior (INVVY) United States $0.466B 1.68
Crinetics Pharmaceuticals (CRNX) United States $0.437B 0.00
Dermira (DERM) United States $0.430B 0.00
Dova Pharmaceuticals (DOVA) United States $0.427B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.421B 19.12
ImmunoGen (IMGN) United States $0.412B 0.00
Siga Technologies (SIGA) United States $0.411B 0.96
Flexion Therapeutics (FLXN) United States $0.409B 0.00
Translate Bio (TBIO) United States $0.405B 0.00
ChemoCentryx (CCXI) United States $0.376B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.354B 0.00
Organogenesis Holdings (ORGO) United States $0.326B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.322B 0.00
CV Sciences (CVSI) United States $0.317B 0.00
Xeris Pharmaceuticals (XERS) United States $0.292B 0.00
Harpoon Therapeutics (HARP) United States $0.286B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.285B 0.00
CannTrust Holdings (CTST) Canada $0.280B 0.00
KalVista Pharmaceuticals (KALV) United States $0.280B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.256B 0.00
Lannett Co Inc (LCI) United States $0.255B 2.48
DURECT (DRRX) United States $0.250B 0.00
OptiNose (OPTN) United States $0.249B 0.00
Concert Pharmaceuticals (CNCE) United States $0.244B 0.00
Recro Pharma (REPH) United States $0.241B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.219B 0.00
Calithera Biosciences (CALA) United States $0.210B 0.00
Ocular Therapeutix (OCUL) United States $0.199B 0.00
Molecular Templates (MTEM) United States $0.186B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.176B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 29.03
Redhill Biopharma (RDHL) Israel $0.147B 0.00
IMV INC (IMV) Canada $0.140B 0.00
Ardelyx (ARDX) United States $0.135B 0.00
GlycoMimetics (GLYC) United States $0.132B 0.00
Jounce Therapeutics (JNCE) United States $0.130B 0.00
Generex Biotechnology (GNBT) United States $0.128B 0.00
Majesco Entertainment (PTE) United States $0.119B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.107B 0.00
MEI Pharma (MEIP) United States $0.106B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.104B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.098B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.092B 0.00
Aquestive Therapeutics (AQST) United States $0.088B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
Cardiome Pharma (CORV) Canada $0.085B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.41
Genocea Biosciences (GNCA) United States $0.082B 0.00
Natural Alternatives (NAII) United States $0.076B 7.62
RENEURON GP (RNUGF) United Kingdom $0.075B 0.00
MediWound (MDWD) Israel $0.074B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.074B 0.00
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 598.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
China SXT Pharmaceuticals (SXTC) China $0.068B 0.00
Otonomy (OTIC) United States $0.067B 0.00
Novan (NOVN) United States $0.065B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.063B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Capnia (SLNO) United States $0.057B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Aclaris Therapeutics (ACRS) United States $0.033B 0.00
Melinta Therapeutics (MLNT) United States $0.032B 0.00
PharmAthene (ALT) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.43
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.002B 0.00
Xenetic Biosciences (XBIO) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00